首页|期刊导航|中国药物评价|液质联用法检测延胡索饮片中5种违规添加着色剂

液质联用法检测延胡索饮片中5种违规添加着色剂OA

Quantitative Determination of Five Illegal Colorants in Corydalis Yanhusuo Decoction Pieces by HPLC-MS/MS

中文摘要英文摘要

目的:建立液质联用法检测延胡索饮片中5种人工着色剂(柠檬黄、日落黄、金橙Ⅱ、金胺O、酸性黄36).方法:采用高效液相串联质谱(HPLC-MS/MS)法,色谱柱为Aglient Eclipse Plus C18(2.1 mm × 100 mm,2.2 μm),流动相为乙腈-0.02 mol·L-1乙酸铵溶液(梯度洗脱),柱温40 ℃,流速0.3 mL·min-1,电喷雾(ESI)离子源,正、负离子扫描(MRM模式).结果:柠檬黄、日落黄在0.40~20.00μg·mL-1范围内,金橙Ⅱ、金胺O、酸性黄36在0.05~2.50 μg·mL-1范围内线性关系良好,线性相关系数r均大于0.99;日落黄、柠檬黄的检出限为0.1 μg·mL-1,金橙Ⅱ、金胺O、酸性黄36的检出限为0.02 μg·mL1,平均回收率为89.6%~97.5%.采用该方法对市售的10批延胡索饮片进行检测,均未检出上述5种人工着色剂.结论:建立的方法具有高特异性和极低检测限,能快速检测延胡索饮片中是否含有非法人工着色剂,可用于延胡索饮片的质量控制.

Objective:To establish a method for the determination of five yellow pigments(Lemon yellow,Sunset yellow,Orange Ⅱ,Auramine O,Acid yellow 36)added into corydalis rhizoma pieces by HPLC-MS/MS.Methods:The analysis was performed with Aglient triple quadrupole mass spectrometer.Electrospray ion(ESI)was adopted as the ion source with positive and negative ion scanning mode(MRM).The Aglient Eclipse Plus C18(2.1 mm × 100 mm,2.2 μm)column was used with acetonitrile-0.02 mol·L-1 ammonium acetate solution as the mobile phase.The flow rate was 0.3 mL·min-1,the columm temperature was 40 ℃.Results:The result showed good linearity in the ranges of 0.40-20.00 μg·mL-1 for lemon yellow and sunset yellow,0.05-2.50 μg·mL-1 for orange Ⅱ,auramine O and acid yellow 36.The limits of detection were 0.1 μg·mL-1 and 0.02 μg·mL-1.The average recovery of five yellow pigments was in the range of 89.6%-97.5%.None of the above five yellow pigments were detected in 10 batches of corydalis rhizoma pieces.Conclusion:The method is convenient,reliable and accurate,and can be used for the detection of yellow pigments in corydalis rhizoma pieces.It's necessary for the quality control of corydalis rhizoma pieces.

王劲;郭衍珩;周欣

菏泽市食品药品检验检测研究院,山东菏泽 274000菏泽市食品药品检验检测研究院,山东菏泽 274000菏泽市食品药品检验检测研究院,山东菏泽 274000

医药卫生

延胡索饮片柠檬黄日落黄金橙Ⅱ金胺O酸性黄36

Corydalis rhizoma piecesLemon yellowSunset yellowOrange ⅡAuramine OAcid yellow 36

《中国药物评价》 2025 (3)

177-182,6

评论